BERYLLIUM
Beryllium is a developer of pharmaceutical products that treat immune and central nervous system diseases. The company was founded in Bedford, Massachusetts.
BERYLLIUM
Industry:
Biopharma Biotechnology Health Care Manufacturing Pharmaceutical
Address:
Bedford, Massachusetts, United States
Country:
United States
Total Employee:
11+
Status:
Active
Contact:
617-652-4000
Total Funding:
7.5 M USD
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aerial BioPharma
Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.
Biomeasure
Biomeasure is a developer of non-invasive health assesment tools.
Carmel Biosciences
Carmel Biosciences develops prescription drugs and nutraceuticals for cardiovascular, metabolic, and central nervous system diseases.
Crozet BioPharma LLC
Crozet BioPharma LLC is a developer of biological products that prevent or treat important human diseases.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Glycomed
Glycomed develops and manufactures pharmaceutical products based on complex carbohydrates, used in the treatment of inflammatory diseases.
Juvantia Pharma
Juvantia Pharma is discovers and develops pharmaceutical products for neurological and cardiovascular disorders.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Neurosearch
Neurosearch is a biopharmaceutical company developing pharmaceutical agents for ion channel and central nervous system disorders.
Nexmed
Nexmed designs and develops pharmaceutical products to treat patients well being and unmet medical needs.
SipNose
SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.